- Home
- BTAI vs HUIZ Comparison
BTAI vs HUIZ Comparison
Compare BTAI & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- HUIZ
- Stock Information
- Founded
- BTAI 2017
- HUIZ 2006
- Country
- BTAI United States
- HUIZ China
- Employees
- BTAI N/A
- HUIZ N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- HUIZ Specialty Insurers
- Sector
- BTAI Health Care
- HUIZ Finance
- Exchange
- BTAI Nasdaq
- HUIZ Nasdaq
- Market Cap
- BTAI 28.7M
- HUIZ 26.8M
- IPO Year
- BTAI 2018
- HUIZ 2020
- Fundamental
- Price
- BTAI $0.36
- HUIZ $2.73
- Analyst Decision
- BTAI Strong Buy
- HUIZ
- Analyst Count
- BTAI 4
- HUIZ 0
- Target Price
- BTAI $5.00
- HUIZ N/A
- AVG Volume (30 Days)
- BTAI 949.6K
- HUIZ 297.0K
- Earning Date
- BTAI 11-14-2024
- HUIZ 12-10-2024
- Dividend Yield
- BTAI N/A
- HUIZ N/A
- EPS Growth
- BTAI N/A
- HUIZ N/A
- EPS
- BTAI N/A
- HUIZ 0.30
- Revenue
- BTAI $2,276,000.00
- HUIZ $154,359,355.00
- Revenue This Year
- BTAI $164.86
- HUIZ N/A
- Revenue Next Year
- BTAI $69.74
- HUIZ $10.46
- P/E Ratio
- BTAI N/A
- HUIZ $9.15
- Revenue Growth
- BTAI 83.25
- HUIZ N/A
- 52 Week Low
- BTAI $0.35
- HUIZ $0.43
- 52 Week High
- BTAI $4.17
- HUIZ $10.58
- Technical
- Relative Strength Index (RSI)
- BTAI 32.49
- HUIZ 57.08
- Support Level
- BTAI $0.35
- HUIZ $2.70
- Resistance Level
- BTAI $0.52
- HUIZ $10.58
- Average True Range (ATR)
- BTAI 0.06
- HUIZ 0.90
- MACD
- BTAI -0.00
- HUIZ 0.10
- Stochastic Oscillator
- BTAI 2.92
- HUIZ 21.97
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.